Trial Profile

The Additive Effect of Vitamin K Supplementation and Bisphosphonate on Fracture Risk in Post-menopausal Osteoporosis.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 02 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Menatetrenone (Primary) ; Phytomenadione (Primary) ; Alendronic acid; Bisphosphonates
Indications Metabolic bone diseases; Postmenopausal osteoporosis
Focus Therapeutic Use
Acronyms VITKANDOP

Most Recent Events

17 Oct 2020 Status changed from active, no longer recruiting to completed.
12 Feb 2020 Planned End Date changed from 1 Mar 2020 to 31 Mar 2020.
12 Feb 2020 Planned primary completion date changed from 1 Mar 2020 to 31 Mar 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com